Clark Capital Management Group’s ResMed RMD Stock Holding History

Clark Capital Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,385	Closed	-$368K	–	316
2017 Q3	$368K	Buy	+5,385	New	+$412K	0.01%	263
2016 Q3	–	Sell	-5,385	Closed	-$340K	–	327
2016 Q2	$340K	Hold	5,385	–	–	0.02%	257
2016 Q1	$311K	Hold	5,385	–	–	0.02%	267
2015 Q4	$289K	Hold	5,385	–	–	0.02%	268
2015 Q3	$274K	Hold	5,385	–	–	0.02%	267
2015 Q2	$304K	Hold	5,385	–	–	0.03%	266
2015 Q1	$387K	Hold	5,385	–	–	0.04%	247
2014 Q4	$302K	Hold	5,385	–	–	0.03%	249
2014 Q3	$265K	Hold	5,385	–	–	0.02%	253
2014 Q2	$273K	Sell	5,385 -75	-1%	-$3.72K	0.02%	266
2014 Q1	$244K	Hold	5,460	–	–	0.02%	292
2013 Q4	$257K	Sell	5,460 -28,352	-84%	-$1.44M	0.02%	290
2013 Q3	$1.79M	Buy	33,812 +266	+0.8%	+$12.9K	0.14%	113
2013 Q2	$1.51M	Buy	+33,546	New	+$1.59M	0.14%	107

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Clark Capital Management Group's RMD Position: Q4 2017 in Review

Clark Capital Management Group sold out of ResMed (RMD) in Q4 2017, closing a stake of 5,385 shares — an estimated $368K sold.

Clark Capital Management Group first reported a position in RMD in Q2 2013 and held it in 14 quarters. The position peaked at $1.79M in Q3 2013. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

Clark Capital Management Group reported no remaining ResMed position as of Q4 2017 after selling out during the quarter.
Clark Capital Management Group sold 5,385 ResMed shares in Q4 2017, an estimated $368K.
Clark Capital Management Group first reported a position in ResMed in Q2 2013 and held it in 14 quarters.
Clark Capital Management Group's ResMed position peaked at $1.79M in Q3 2013.
415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on Clark Capital Management Group's 13F filing for Q4 2017, filed 14 Feb 2018.